Amylyx looks to cover financial gap left by Relyvrio with avexitide deal, says GlobalData GlobalData Jul 2, 2024 The acquisition is a strategic action by Amylyx following the failure of its lead amyotrophic lateral sclerosis (ALS) therapy,…
